De bevindingen van de trial zijn ‘evidence-based’ en be-vestigen de resultaten van de eerdergenoemde meta-analyse.8 Pas indien aangetoond zou worden dat de re- sultaten in ons land of in de eigen kliniek anders.
A family of drugs that activate certain proteins in the body called peroxisome proliferator-activated receptors (PPARs). The PPAR agonists can help to improve blood glucose levels and levels of blood lipids (fats and cholesterol) and may also reduce risks of atherosclerosis because PPARs regulate.